Richard Stephen

Richard Stephen is listed in filings as Director at Anika Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 24, 2025, including 2 public disclosures. Recent filings connect the profile to Anika Therapeutics, Inc. (ANIK). The current snapshot covers public activity from Jul 11, 2024 to Jun 24, 2025. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.